Established in 1968, PICCAN has been an emblem of trust and excellence in infant care OTC medicine within Nigeria, remaining a steadfast brand over the years. In 1994, KIMCO took the helm by acquiring PICCAN from Unilever, initiating a new phase of growth and development. In 2017, Anchor Brands cemented a pivotal agreement with KIMCO to steer PICCAN's strategy, foster product evolution, and expand its range across Africa.

At Anchor Brands, we uphold a meticulous approach towards each new PICCAN product, ensuring unparalleled quality and service to both our trade partners and consumers. As we honour PICCAN's rich legacy, we are excited to announce our forthcoming venture into local production, set to commence in July 2024. This strategic move not only signifies our dedication to the region but also heralds increased investment and opportunities for growth. By embracing local production, we aim to enhance accessibility and provide tailored solutions that resonate with the needs of our local communities, further solidifying PICCAN's position as a cornerstone in infant care within the region.

The inaugural product to roll off our production line in Nigeria will be our flagship item, "PICCAN Teething Remedy," uniquely formulated to address infants' teething discomfort. Following this debut, we are preparing to introduce a lineup of trusted essentials, including PICCAN Ibuprofen, PICCAN Paracetamol, and PICCAN Nappy Rash Cream. These upcoming additions to our product range underscore our commitment to delivering effective and essential solutions that cater to the holistic care of babies and infants across the region.